In addition, TYMS is associated with tumor metastasis and aggressive phenotypes of several tumors, such as glioma [31], breast cancer [32], prostate cancer [33], and soft tissue sarcoma [34]. This evidence concerns the gene TYMS and prostate carcinoma.